...
首页> 外文期刊>Journal of chemotherapy >Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature.
【24h】

Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature.

机译:用阿仑妥珠单抗治疗的慢性淋巴细胞性白血病患者的新型隐球菌致命败血症:病例报告和文献复习。

获取原文
获取原文并翻译 | 示例
           

摘要

Cryptococcosis is a disseminated fungal disease typically associated with immunosuppression and characterized by high mortality rates. Cryptococcus neoformans has been reported to be isolated from blood cultures in around 20% of patients with cryptococcosis, and cryptococcemia has been correlated with poor prognosis. We report a case of fatal C. neoformans fungemia in a neutropenic patient with a history of chronic lymphocytic leukemia treated with alemtuzumab. The patient presented with loss of consciousness and died after 5 days of antifungal therapy with liposomal amphotericin B. The international literature regarding opportunistic infections after immunosuppressive therapy with alemtuzumab with particular attention on fungal infections has also been reviewed.
机译:隐球菌病是一种传播性真菌病,通常与免疫抑制有关,并具有高死亡率。据报道,约20%的隐球菌病患者从血液培养物中分离出新隐球菌,隐球菌病与不良预后相关。我们报道了一名中性粒细胞减少症患者的致命性新孢子虫真菌病病例,该病患者接受了alemtuzumab治疗的慢性淋巴细胞性白血病的病史。患者表现出意识丧失,并在用脂质体两性霉素B进行抗真菌治疗5天后死亡。国际文献也对关于用Alemtuzumab进行免疫抑制治疗后的机会性感染进行了综述,其中特别关注真菌感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号